Therapy and interventions

ey0015.10-23 | Therapy and interventions | ESPEYB15

10.23 Effect of financial incentives on glucose monitoring adherence and glycemic control among adolescents and young adults with T1DM: a randomized clinical trial

CA Wong , VA Miller , K Murphy , D Small , CA Ford , SM Willi , J Feingold , A Morris , YP Ha , J Zhu , W Wang , MS Patel

To read the full abstract: JAMA Pediatr. 2017;171:1176-1183Adolescence is certainly the most difficult age for reaching T1DM treatment and HbA1c goals. In this age group, most patients have deteriorated metabolic control, and higher risk for acute complications, such as severe hypoglycemia and DKA. Getting into therapeutic contact is very hard in this period of life for diabetes teams ...

0 shares

ey0015.10-24 | Therapy and interventions | ESPEYB15

10.24 Management of T1DM with a very low-carbohydrate diet

BS Lennerz , A Barton , RK Bernstein , RD Dikeman , C Diulus , S Hallberg , ET Rhodes , CB Ebbeling , EC Westman , WS Yancy Jr , DS Ludwig

To read the full abstract: Pediatrics. 2018;14. pii: e20173349On social media, parents of children with T1DM can find several sources that recommend ‘low carb diets’. Especially on lay community websites, such diets are recommended to eliminate blood glucose spikes and improve metabolic control. On the other hand, parents should be aware that the risk for hypoglycemia and especially ...

0 shares

ey0015.10-25 | Therapy and interventions | ESPEYB15

10.25 A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with T1DM in the home or school setting

LC Deeb , H Dulude , CB Guzman , S Zhang , BJ Reiner , CA Piché , S Pradhan , XM Zhang

To read the full abstract: Pediatr Diabetes. 2018 19(5):1007-1013Severe hypoglycemia is one of the most threatening events in management of diabetes for parents and relatives. Although parents and patients are taught about the management in the acute situation, many are unable to use injectable glucagon. For moderate hypoglycemia, injectable glucagon seems to be no alternative for most caregivers. N...

0 shares

ESPE Yearbook of Paediatric Endocrinology

Yearbook of Paediatric Endocrinology 2018

10 Type 1 Diabetes Mellitus

10.23 Effect of financial incentives on glucose monitoring adherence and glycemic control among adolescents and young adults with T1DM: a randomized clinical trial

10.24 Management of T1DM with a very low-carbohydrate diet

10.25 A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with T1DM in the home or school setting

BiosciAbstracts